The University of Chicago Header Logo

Connection

Rita Nanda to BRCA2 Protein

Back to Details
This is a "connection" page, showing publications Rita Nanda has written about BRCA2 Protein.
Rita Nanda
Connection Strength
0.138
BRCA2 Protein
  1. Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083. Clin Cancer Res. 2017 Aug 01; 23(15):4066-4076.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.